Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_assertion type Assertion NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_head.
- NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_assertion description "[Together, these results support the view that CD40 activation of B-CLL cells might reverse T-cell anergy against the neoplastic cell clone, although the character of the immune response depends on the major histocompatibility complex (MHC) background on which the CLL or tumor antigens are presented.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_provenance.
- NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_assertion evidence source_evidence_literature NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_provenance.
- NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_assertion SIO_000772 10068672 NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_provenance.
- NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_assertion wasDerivedFrom befree-20140225 NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_provenance.
- NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_assertion wasGeneratedBy ECO_0000203 NP326282.RAzLKYWV0jVgvjGF4Yh9O6vbNVOZinCz8iQznEUJGfApw130_provenance.